New cocktail of chemo drugs shows promise for tough pancreatic cancer

This study tested a combination of three chemotherapy drugs (paclitaxel protein bound, gemcitabine, and cisplatin) in 34 people with metastatic pancreatic cancer that had not been treated before. If the cancer got worse, a fourth drug (paricalcitol) was added. The goal was to see how well the treatment shrank tumors and how long it kept the cancer from growing. The study is complete, and results help guide future treatment options.